ArticleTargeted oncology2019

Effect of Early Adverse Events on Survival Outcomes of Patients with Metastatic Colorectal Cancer Treated with Ramucirumab.

Huezin H Lim et al.PubMed ↗Publisher ↗

No numbers read from the abstract.